(Q52899086)

9 May 2018

title

Quercetin induces apoptosis and enhances 5-FU therapeutic efficacy in hepatocellular carcinoma. (English)

1 reference

9 May 2018

author name string

Wei Dai

1

1 reference

9 May 2018

Quangen Gao

2

1 reference

9 May 2018

Jianping Qiu

3

1 reference

9 May 2018

Jianmao Yuan

4

1 reference

9 May 2018

Guoliang Wu

5

1 reference

9 May 2018

Genhai Shen

6

1 reference

9 May 2018

publication date

1 December 2015

1 reference

9 May 2018

published in

Tumor Biology

1 reference

9 May 2018

volume

37

1 reference

9 May 2018

issue

5

1 reference

9 May 2018

page(s)

6307-6313

1 reference

9 May 2018

https://scigraph.springernature.com/pub.10.1007/s13277-015-4501-0

exact match

0 references

cites work

Chronic hepatitis c genotype-4 infection: role of insulin resistance in hepatocellular carcinoma

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-4501-0

EASL-EORTC clinical practice guidelines: management of hepatocellular carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-4501-0

5-Fluorouracil: mechanisms of action and clinical strategies

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-4501-0

Quercetin Enhances Chemosensitivity to Gemcitabine in Lung Cancer Cells by Inhibiting Heat Shock Protein 70 Expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-4501-0

Low concentration of quercetin antagonizes the cytotoxic effects of anti-neoplastic drugs in ovarian cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-4501-0

Quercetin Induces Antiproliferative Activity Against Human Hepatocellular Carcinoma (HepG2) Cells by Suppressing Specificity Protein 1 (Sp1).

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-4501-0

Antiproliferative activity of long chain acylated esters of quercetin-3-O-glucoside in hepatocellular carcinoma HepG2 cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-4501-0

Survivin: key regulator of mitosis and apoptosis and novel target for cancer therapeutics

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-4501-0

Pharmacological inhibition of the Bcl-2 family of apoptosis regulators as cancer therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-4501-0

Inhibitors of the anti-apoptotic Bcl-2 proteins: a patent review

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-4501-0

Targeting survivin in cancer: patent review

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-4501-0

Enforced dimerization of BAX results in its translocation, mitochondrial dysfunction and apoptosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-4501-0

Zerumbone induced apoptosis in liver cancer cells via modulation of Bax/Bcl-2 ratio

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-4501-0

Epigenetic silencing of BCL6B inactivates p53 signaling and causes human hepatocellular carcinoma cell resist to 5-FU.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-4501-0

EASL–EORTC Clinical Practice Guidelines: Management of hepatocellular carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-4501-0

Finasteride induces apoptosis via Bcl-2, Bcl-xL, Bax and caspase-3 proteins in LNCaP human prostate cancer cell line.

21 January 2018

1 reference

12 December 2020

Protein kinase A RIalpha antisense inhibition of PC3M prostate cancer cell growth: Bcl-2 hyperphosphorylation, Bax up-regulation, and Bad-hypophosphorylation

1 reference

12 December 2020

The role of apoptosis in cancer development and treatment response

1 reference

12 December 2020

Regulation of tumor cell apoptotic sensitivity during the cell cycle (Review).

1 reference

12 December 2020

Corticosteroid co-treatment induces resistance to chemotherapy in surgical resections, xenografts and established cell lines of pancreatic cancer

1 reference

12 December 2020

10.1007/S13277-015-4501-0

Identifiers

DOI

1 reference

9 May 2018

PubMed ID

26628295

1 reference

9 May 2018